Literature DB >> 25437920

Role of protein phosphorylation in excitation-contraction coupling in taurine deficient hearts.

K C Ramila1, Chian Ju Jong1, Viktor Pastukh1, Takashi Ito2, Junichi Azuma2, Stephen W Schaffer3.   

Abstract

Taurine is a beta-amino acid found in very high concentration in the heart. Depletion of these intracellular stores results in the development of cardiomyopathy, thought to be mediated by abnormal sarcoplasmic reticular (SR) Ca(2+) transport. There is also evidence that taurine directly alters the Ca(2+) sensitivity of myofibrillar proteins. Major regulators of SR Ca(2+) ATPase (SERCA2a) are the phosphorylation status of a regulatory protein, phospholamban, and SERCA2a expression, which are diminished in the failing heart. The failing heart also exhibits reductions in myofibrillar Ca(2+) sensitivity, a property regulated by the phosphorylation of the muscle protein, troponin I. Therefore, we tested the hypothesis that taurine deficiency leads to alterations in SR Ca(2+) ATPase activity related to reduced phospholamban phosphorylation and expression of SERCA2a. We found that a sequence of events, which included elevated protein phosphatase 1 activity, reduced autophosphorylation of CaMKII, and reduced phospholamban phosphorylation, supports the reduction in SR Ca(2+) ATPase activity. However, the reduction in SR Ca(2+) ATPase activity was not caused by reduced SERCA2a expression. Taurine transporter knockout (TauTKO) hearts also exhibited a rightward shift in the Ca(2+) dependence of the myofibrillar Ca(2+) ATPase, a property that is associated with an elevation in phosphorylated troponin I. The findings support the observation that taurine deficient hearts develop systolic and diastolic defects related to reduced SR Ca(2+) ATPase activity, a change mediated in part by reduced phospholamban phosphorylation.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  cardiomyopathy; phospholamban; protein phosphorylation; sarcoplasmic reticular Ca2+ ATPase activity; taurine; troponin I

Mesh:

Substances:

Year:  2014        PMID: 25437920     DOI: 10.1152/ajpheart.00497.2014

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  19 in total

1.  Metabolomic analysis of serum and myocardium in compensated heart failure after myocardial infarction.

Authors:  M Dan McKirnan; Yasuhiro Ichikawa; Zheng Zhang; Alice E Zemljic-Harpf; Sili Fan; Dinesh Kumar Barupal; Hemal H Patel; H Kirk Hammond; David M Roth
Journal:  Life Sci       Date:  2019-02-05       Impact factor: 5.037

2.  The Regulatory Effects of Taurine on Neurogenesis and Apoptosis of Neural Stem Cells in the Hippocampus of Rats.

Authors:  Gaofeng Wu; Jiaqi Zhou; Maohong Yang; Chang Xu; Huiping Pang; Xia Qin; Shumei Lin; Jiancheng Yang; Jianmin Hu
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 3.  Beneficial Effects of Taurine on Metabolic Parameters in Animals and Humans.

Authors:  Minkyung Bae; Kainat Ahmed; Jung-Eun Yim
Journal:  J Obes Metab Syndr       Date:  2022-06-07

4.  Mitochondrial defects associated with β-alanine toxicity: relevance to hyper-beta-alaninemia.

Authors:  Aza Shetewy; Kayoko Shimada-Takaura; Danielle Warner; Chian Ju Jong; Abu-Bakr Al Mehdi; Mikhail Alexeyev; Kyoko Takahashi; Stephen W Schaffer
Journal:  Mol Cell Biochem       Date:  2016-03-29       Impact factor: 3.396

5.  Role of Mitochondria and Endoplasmic Reticulum in Taurine-Deficiency-Mediated Apoptosis.

Authors:  Chian Ju Jong; Takashi Ito; Howard Prentice; Jang-Yen Wu; Stephen W Schaffer
Journal:  Nutrients       Date:  2017-07-25       Impact factor: 5.717

6.  Protective role of taurine against oxidative stress (Review).

Authors:  Stella Baliou; Maria Adamaki; Petros Ioannou; Aglaia Pappa; Mihalis I Panayiotidis; Demetrios A Spandidos; Ioannis Christodoulou; Anthony M Kyriakopoulos; Vassilis Zoumpourlis
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

Review 7.  Nutritional Deficiency in Patients with Heart Failure.

Authors:  Edoardo Sciatti; Carlo Lombardi; Alice Ravera; Enrico Vizzardi; Ivano Bonadei; Valentina Carubelli; Elio Gorga; Marco Metra
Journal:  Nutrients       Date:  2016-07-22       Impact factor: 5.717

8.  Circulating Glutamate and Taurine Levels Are Associated with the Generation of Reactive Oxygen Species in Paroxysmal Atrial Fibrillation.

Authors:  Shintaro Takano; Kousuke Fujibayashi; Nakaba Fujioka; Ei-ichi Ueno; Minoru Wakasa; Yasuyuki Kawai; Kouji Kajinami
Journal:  Dis Markers       Date:  2016-01-06       Impact factor: 3.434

Review 9.  Effects and Mechanisms of Taurine as a Therapeutic Agent.

Authors:  Stephen Schaffer; Ha Won Kim
Journal:  Biomol Ther (Seoul)       Date:  2018-05-01       Impact factor: 4.634

10.  Effects of the kinase inhibitor sorafenib on heart, muscle, liver and plasma metabolism in vivo using non-targeted metabolomics analysis.

Authors:  Brian C Jensen; Traci L Parry; Wei Huang; Ju Youn Beak; Amro Ilaiwy; James R Bain; Christopher B Newgard; Michael J Muehlbauer; Cam Patterson; Gary L Johnson; Monte S Willis
Journal:  Br J Pharmacol       Date:  2017-11-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.